A study conducted at Glasgow Caledonian University has confirmed the efficacy of the Tristel Duo sporicidal surface disinfection system against two opportunistic pathogens in the hospital environment
The Tristel Duo sporicidal surface disinfection system was tested against five representative strains of epidemic methicillin resistant staphylococcus aureus (EMRSA) and human norovirus.
Tristel Duo comprises disinfectant-impregnated wipes used with a chlorine dioxide foam dispensed immediately before use.
A surface test methodology was used to evaluate the efficacy of the system against five common strains of EMRSA and the accepted Norovirus surrogate, feline calicivirus.
Test data indicate that Tristel Duo effectively reduces each of the five global EMSRA strains by least 5(log)10 following the recommended contact time of 30 seconds.
For the Norovirus surrogate, infectivity was completely removed to the level of sensitivity of the assay used.
Now in a new cost-effective packaging format that allows users to purchase a starter pack followed by refills as needed, Tristel Duo is proving highly effective and convenient for deep cleaning of near-patient equipment.
As well as MRSA and norovirus, it is active against a wide range of organisms, including clostridium difficile, bacillus subtilis, mycobacterium tuberculosis and acinetobacter baumanii.
